recent study journal clinical psychopharmacology found aripiprazole abilify offered benefit placebo treating biploar depression well least results showed discussion section told bit different story end eight weeks abilify failed beat placebo either montgomery asberg depression rating scale clinical global impressions bipolar severity illness scale rare industry sponsored article reports negative results would nigh impossible find published industry sponsored study failed put happy spin negative results sure results negative study dosing different treatment could worked always loophole possibility results would dandy something different check possible dosing regimen used current studies may high patient group titration rapid specifically unexpectedly high rates discontinuation caused reason aes suggest aripiprazole starting dose mg may high dose titration weekly adjustments mg increments according clinical response tolerability may rapid however preliminary data indicate aripiprazole may potential value adjunctive therapy patients bipolar depression future studies focus use aripiprazole adjunctive therapy using better tolerated dosing schedule conservative escalation may greater value treatment patients bipolar depression favorite part although improvements madrs total scores current aripiprazole studies separate statistically significantly placebo end point significant effects observed aripiprazole monotherapy within first weeks clinically meaningful similar effects seen olanzapine monotherapy lamotrigine monotherapy patients bipolar depression ok argument treatment work end weeks effects weeks really super duper impressive gim me break authors present actual numbers madrs primary manner depression assessed rather data presented figures um science supposed based numbers provided text paper weeks difference scores abilify placebo looks little points madrs rating scale spans drug makes person points better relative placebo findings clinically meaningful keep lowering bar fellas discussion reaches rescue reputation abilify fair also point couple occasions abilify particularly efficacious end weeks related worse safety tolerability profile placebo fact relative studies i dissed regarding sunny presentation unimpressive results like one current abilify article model fair discussion side note akathisia reported quarter patients taking abilify funny thing akathisia well defined study many others problem movements mental tension something else would seem important know given abilify apparently causes akathisia droves pubmed search aripiprazole akathisia see i mean couple descriptions akathisia follow increased tenseness restlessness insomnia feeling uncomfortable first day treatment reacted marked anxiety weepiness second day felt terrible marked panic night medication cancelled another movement disorder characterized feeling inner restlessness compelling need constant motion well actions rocking standing sitting lifting feet marching spot crossing uncrossing legs sitting people akathisia unable sit keep still complain restlessness fidget rock foot foot pace